TABLE 3.

Clinical details of patients^a

Patient ID	pVL (copies/ml)	Time (mo)	% CD4+ CD3+	CD4 count	cVL (copies/105 cells)	iVL (copies/105 cells)	Therapyb	Other drug therapyc	Therapy outcomed
1	<400	25	12	465	414	ND	TRIZ, EFV
2	<50	>81	33	971	1,584	3
3	<50	>16	26	327	3,540	18	COM, K	Y
4	<400	80	24	410	3,485	4
5	<400	57	29	641	2,011	12	COM, NVP
6	<400	29	8	196	32	14	ABC, 3TC, NVP
	<400			297	ND	ND	ABC, 3TC, NVP
	<40		12	354	287	21	ABC, 3TC, NVP
7	<400	>16	35	651	47	36	3TC, STAV, NVP
	<40			767	87	66	3TC, EFV, ABC
	<40				36	ND	3TC, EFV, ABC
8	<400	53	26	532	5,110	10	COM, NVP	Y
	<400	57	29	641	2,011	60	COM, NVP
9	<400	77	27	327	11,608	3
	<400	80	24	410	3,485	4
10	<50	18	16	325	2,535	38	COM, K		F
11	35,500		14	473	18	8
12	<50	>24	26	575	170	INV	EFV, COM
	<40	>30	29	612	99	16	EFV, COM
13	<400				222	INV
14	<50	>69	18	173	164	ND
15	205,000				229	INV
16	800		30	457	382	INV	COM, EFV
17	<400	68	10	243	9	ND	3TC, TDF, EFV	Y
18	<50		21	527	47	76	TRIZ, NVP	Y
19	<50	>10	13	351	226	211	TDF, 3TC, EFV	Y	F
20	<400	22	13	433	8,584	INV	TRIZ, EFV	Y
21	87,000		13	103	129	36	NVP, COM	Y
22	<400	>24	38		26	ND	COM, NVP
	<40	>18	36	1,270	73	6	COM, NVP
23	<400	19	37	1,059	27	43	AZT, 3TC, NVP		F
24	10,000		14	321	1,714	INV	3TC, STAV	Y
25	1,700		22	403	6	ND	TRIZ
	210				36	35	TRIZ, ATAZ		F
26	<50	>78	22	437	ND	ND
27	89,000		14	112		ND	3TC, K, TDF	Y
	47,000		13	151	43	ND	3TC, K, TDF	Y
28	<50	22	31	357	152	ND	COM, EFV
29	<400	>78	8	278	156	INV
30	1,900		12	107	10	INV	COM, EFV	Y
	110	>11	14	287	9,458	INV	EFV, TRIZ, RTV
		>12	13	310	ND	ND	COM, EFV
31	4,000		16	347	123	INV
32	<400	42	18	234	30,481	37
	<400	45	21	305	1,176	7
33	800		26	531	247	102	3TC, K, TDF
34	<50	>81	33	971	1,584	9
35	<400	45	52	1,088	19	ND
36	2,300		30	540	10	ND	TDF, 3TC, K
37	<400	35	19	307	10	INV	AZT, 3TC, NVP	Y
38	27,000		41	628	88	84

^aND, not detected or below the limit of the assay; INV, invalid (result from Alu-minus control PCR greater or equal to Alu PCR).

^bTRIZ, Trizivir; EFV, efavirenz; COM, Combivir; K, Kaletra; NVP, nevirapine; ABC, abacivir; 3TC, lamivudine; STAV, stavudine; TDF, tenofovir; RTV, ritonavir; ATZ, atazanavir.

^cA Y indicates that other drug therapy included antidepressant, antifungal, and antibacterial drugs.

^dAn F indicates that at 12 months postmeasurement, treatment had failed.